PPM1F

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, PPM1F mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated PPM1F data layer compared with 23 for mass-spec protein and 12 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PPM1F mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PPM1F expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

HNSC, CCRCC, and LUAD are the cancer types where PPM1F mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSTertileAll0.8890.286.00637view →
CCRCCDFSQuartileIII,IV0.8750.342.01013view →
LUADDFSTertileAll0.9060.402.00611view →
PDACOSQuartileAll0.5470.297.0322view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

PPM1F–HNSC (DFS)

Kaplan–Meier survival curve for PPM1F mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration